19 juin 2021
09h00 - 10h30 HAE
07h00 - 08h30 HAR
06h00 - 07h30 HAP
Daniel Bichet
Professor of Medecine, Pharmacology and Physiology, l’Université de Montréal
Nephrologist, Hôpital du Sacré-Cœur de Montréal
Montréal, QC

À la fin de cette activité d’apprentissage, les participants seront mieux en mesure de :
  • To appreciate the need for maintaining appropriate evidence based use of RAAS blockade in patients with CKD and or CHF who have hyperkalemia
  • To consider options for chronic hyperkalemia management in patients with CKD

Daniel G. Bichet, MD is Professor of Medicine, Pharmacology and Physiology at the Université de Montréal and a staff nephrologist at the Hôpital du Sacré-Coeur de Montréal. He obtained his medical degree at the Université de Besançon (France) and completed additional clinical training at the Hôtel-Dieu de Montréal Hospital (Université de Montréal), Montréal General Hospital, and Royal Victoria Hospital (McGill University). He did a research fellowship at the University of Colorado Health Sciences Center under the mentorship of Dr. Robert Schrier with the encouragements of Dr Julien Marc-Aurèle in Montreal. Dr. Bichet obtained a Canadian Institutes Health Research Chair in Genetics of Renal Diseases from 2003 to 2010. He received the Jonathan Ballon Award of the Quebec Heart and Stroke Foundation, was a scholar of the Heart and Stroke Foundation of Canada and le Fonds de la recherche en santé du Québec (FRSQ). He was also a recipient of a Career Investigator Award of the FRSQ.

Dr. Bichet’s research includes fundamental life-sustaining homeostatic networks for water and osmotic pressure balance in human physiology. His laboratory is contributing to the prevention of extreme dehydration states in children with polyuric disorders (Nephrogenic Diabetes Insipidus). Dr. Bichet received the Medal of the Kidney Foundation of Canada in 1998, a Doctorat Honoris Causa from the University of Nancy (France) in 1999, and the Jean Hamburger Medal (the highest distinction of the European Society of Nephrology) in 2010. Bichet D.G. Regulation of thirst and vasopressin release, Annual Review of Physiology, Feb 10;81:359 373. 2019. Bichet DG. GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus. Eur J Endocrinol. 2020 Aug;183(2):R29-R40. doi: 10.1530/EJE-20-0114.PMID: 32580146 Review.

À la fin de cette activité d’apprentissage, les participants seront mieux en mesure de :